Janssen secures two positive CHMP opinions for Imbruvica label expansions
July 1, 2019Sales and Marketing CHMP, EMA, Europe, Janssen, imbruvica, pharma
Janssen’s Imbruvica (ibrutinib) has racked up two positive recommendations from the European Medicines Agency’s Committee for Medicinal Products for Human …
Novartis says it did not send substances for chemical weapons to Syria
July 1, 2019Sales and Marketing Brenntag, Novartis, Syria, chemical weapons, pharma, war
Swiss firm Novartis has said that it did not send chemicals that could be used to make chemical weapons to …
FDA greenlights Pfizer biosimilar version of Genentech’s Avastin
July 1, 2019Sales and Marketing Cancer, Genentech, Pfizer, pharma, pncology
Pfizer is celebrating the approval by the FDA of Zirabev, its biosimilar version of Genentech’s Avastin (bevacizumab), which is now …
Pfizer’s Revatio flops in Phase 3 trial
July 1, 2019Sales and Marketing
American multinational Pfizer has said that Revatio (Sildenafil Citrate) in combination with nitric oxide, has failed to meet its primary …
Medicines recalled after FMD alert
July 1, 2019Sales and Marketing FMD, MHRA, labels, pharma, recall, supply chain
The MHRA has warned patients that batches of drugs for Parkinson’s, epilepsy and blood clots have been taken out of …
Read the July/August edition of Pharmafocus online now!
June 28, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NHS, Orkambi, Trump, UK, brexit, generics, manufacturing compliance, pharma
The latest monthly edition of Pharmafocus, the July/August issue, is available to read for free online now!The UK remains split …
Top Ten most popular articles on Pharmafile.com this week
June 28, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AbbVie, Allergan, Bristol-Myers Squibb, China, GSK, Novartis, Takeda, brexit
This week was diverse as always in terms of news coming out of the pharma industry, but the biggest news …
ImmunoGen to axe 220 positions as part of new restructuring strategy
June 28, 2019Manufacturing and Production, Medical Communications Immunogen, pharma
ImmunoGen has announced that, following an in-depth operational review to “extend the company’s cash runway”, it will be implemented a …
Janssen’s Darzalex combo approved by FDA in transplant-ineligible multiple myeloma patients
June 28, 2019Medical Communications, Sales and Marketing Janssen, darzalex, mutiple myeloma, pharma
Janssen’s Darzalex (daratumumab) has secured FDA approval in combination with lenalidomide and dexamethasone for the treatment of newly diagnosed multiple …
Former FDA Commissioner Scott Gottlieb elected to Pfizer’s Board of Directors
June 28, 2019Medical Communications FDA, Pfizer, Scott Gottlieb, pharma
Dr Scott Gottlieb, who stepped down from his role as the 23rd Commissioner of the FDA earlier this year, has …
Healthcare communications: Time to think differently with patient centricity
June 27, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Spink, patient centricity, pharma
Patient centricity, derived from the NHS-driven thinking “no decision about me, without me”, has been adopted by pharma to understand …
Major review points to success of HPV vaccine, cervical cancer could be eradicated in developed nations
June 27, 2019Research and Development Cancer, HPV, UK, cervical cancer, human papilloma virus, pharma, vaccines
A major new review published in The Lancet has supported the effectiveness of the human papilloma virus (HPV) vaccine in …
FDA approves Dupixent for chronic rhinosinusitis with nasal polyposis
June 27, 2019Sales and Marketing Dupixent, FDA, Sanofi, US, pharma, rhinosinusitis
Regeneron Pharmaceuticals and Sanofi have revealed that their dual IL-4 and IL-13 inhibitor Dupixent (dupilumab) has secured FDA approval in …
Titan Therapeutics’ opioid dependence implant Sixmo approved in Europe
June 27, 2019Sales and Marketing Molteni, Sixmo, Titan Therapeutics, pharma
The European Commission has awarded marketing approval to Sixmo, a subdermal buprenorphine implant from Titan Therapeutics and Molteni, in all …
AstraZeneca’s Imfinzi meets endpoint at Phase 3 interim analysis in extensive-stage small cell lung cancer
June 27, 2019Research and Development AstraZeneca, Imfinzi, pharma
AstraZeneca has lifted the curtain on new Phase 3 data for Imfinzi (durvalumab) in the first-line treatment of extensive-stage small …
Takeda plans to vacate all 1,000 staff from US HQ by the year’s end
June 26, 2019Manufacturing and Production, Medical Communications, Sales and Marketing Shire, Takeda, US, pharma
Takeda has announced its plans to vacate all staff from its US headquarters in Deerfield, Illinois, by the end of …
Rare Group A strep outbreak kills 12 and infects 20 in Essex
June 26, 2019Medical Communications, Research and Development England, NHS, UK, outbreak, pharma
An outbreak of the rare contagious bacteria Group A streptococcal (iGAS) infection in Essex, UK, has resulted in 32 cases …
Novartis provides promising update on Cosentyx in plaque psoriasis
June 26, 2019Research and Development Cosentyx, Novartis, pharma, psoriasis
Novartis has revealed brief new data on its IL-17A antibody Cosentyx (secukinumab) in the treatment off plaque psoriasis, showing that …
Acer’s shares drop 80% as FDA rejects drug for vascular Ehlers-Danlos syndrome
June 26, 2019Research and Development, Sales and Marketing Acer Therapeutics, Edsivo, pharma
Acer Therapeutics has seen its share value plunge by 80% after it emerged that the FDA had turned down its …
AbbVie poised to acquire Allergan for $63 billion
June 26, 2019Research and Development, Sales and Marketing AbbVie, Allergan, acqusition, pharma
The industry has been rocked with the announcement of another pharmaceutical mega-merger, as it emerged that AbbVie had sealed an …
Latest content
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact
